Introduction {#Sec1}
============

Correlations between beat-to-beat alternations in electrocardiographic QT interval (QT or T-wave alternans) and cardiac arrhythmia have been described in classical work \[[@CR13], [@CR25]\] and subsequently confirmed in both clinical studies \[[@CR2], [@CR28], [@CR38]\] and experimental models \[[@CR7], [@CR33], [@CR52]\]. Indeed, the presence of such alternans provides a stronger predictor of arrhythmic risk than is offered by signal-averaged electrocardiography and a prediction of a similar value to that offered by invasive programmed stimulation procedures in current use \[[@CR10]\] (but see \[[@CR45]\]). The association between alternans and arrhythmogenicity is particularly marked at high heart rates (short baseline cycle lengths, BCLs) \[[@CR15], [@CR49]\] and in conditions of congenital and acquired electrocardiographic QT, and therefore action potential, prolongation \[[@CR1], [@CR34], [@CR39], [@CR46], [@CR47], [@CR64]\].

The relationship between heart rate and alternans has previously been analysed by constructing restitution curves which plot relationships between action potential duration (APD) and preceding diastolic interval (DI), as BCL is varied \[[@CR12]\]. Clinical and experimental studies then associated alternans and arrhythmia observed at short BCLs with steeply sloping restitution curves with gradients greater than unity \[[@CR14], [@CR21], [@CR24], [@CR32]\]. The latter would reflect disproportionate decreases in mean APD with DI. Furthermore, manoeuvres which decrease the slopes of restitution curves, such as hyperkalaemia in a tachycardic canine endocardial preparation \[[@CR22]\] and certain cardiotropic drugs in canine and porcine preparations \[[@CR8], [@CR31], [@CR37]\], have been reported to both suppress alternans and exert anti-arrhythmic effects. In contrast, other studies have attributed such alternans to alteration in Ca^2+^ cycling involving the sarcoplasmic reticulum \[[@CR35], [@CR44], [@CR54]\]. Whatever the underlying mechanism, alternans results in temporal variations in the wavelengths of propagating action potentials that could potentially lead to reentry and arrhythmogenesis \[[@CR55]\].

Hypokalaemia is an important clinical cause of acquired QT prolongation and is associated with arrhythmia of various degrees of spatial organisation \[[@CR12], [@CR30], [@CR57]\] suppressible by lidocaine \[[@CR6], [@CR36], [@CR48]\]. The present study uses the monophasic action potential (MAP) technique \[[@CR19], [@CR23]\] and an established Langendorff-perfused murine model \[[@CR18], [@CR40]--[@CR42]\] to explore the effects of hypokalaemia and of lidocaine on alternans and arrhythmogenicity for the first time in any species. These investigations of *temporal* heterogeneities in recovery after depolarization are performed on hearts paced at *short* BCLs, thereby complimenting recent work \[[@CR40], [@CR41]\] which contrastingly examined the contribution of *spatial* heterogeneities at *long* BCLs. This approach successfully demonstrates such phenomena in parallel with the clinical situation and proceeds for the first time to apply Fourier analysis to MAP waveforms and to recordings obtained during hypokalaemia. This analysis demonstrates evolution from a monomorphic to a polymorphic pattern as has previously been reported in other species \[[@CR55], [@CR58], [@CR63]\], thereby further validating the murine model. The presence or absence of alternans and arrhythmogenicity is then related to alterations in the slopes of restitution curves. Thus, while the relationship between APD and BCL has previously been determined \[[@CR20]\], the present study reports restitution curves relating APD to the preceding DI for the first time in a murine system. Use of this murine system further permits the comparison of findings with results obtained from genetically modified examples \[[@CR26]\].

Taken together, these novel findings implicate a dynamic component to arrhythmic substrate under conditions of hypokalaemia for which restitution may furnish a possible underlying mechanism.

Materials and methods {#Sec2}
=====================

Experimental animals {#Sec3}
--------------------

Mice were housed at 21 ± 1°C with 12-h light/dark cycles, were fed sterile chow (RM3 Maintenance Diet, SDS, Witham, Essex, UK) and had free access to water. Wild-type 129 Sv mice aged 3--6 months were used in all experiments. All procedures complied with the UK Animals (Scientific Procedures) Act 1986.

Solutions {#Sec4}
---------

Solutions were based on bicarbonate-buffered Krebs--Henseleit solution (mM: NaCl 119, NaHCO~3~ 25, KCl 4, KH~2~PO~4~ 1.2, MgCl~2~ 1, CaCl~2~ 1.8, glucose 10 and Na-pyruvate 2; pH adjusted to 7.4) and were bubbled with 95% O~2~/5% CO~2~ (British Oxygen Company, Manchester, UK). Hypokalaemic (3.0 mM K^+^) solutions were prepared by reducing the amount of KCl added. Lidocaine-containing solutions were prepared by adding lidocaine (Sigma-Aldrich, Poole, UK) to a final concentration of 10 μM.

Preparation {#Sec5}
-----------

A Langendorff perfusion protocol previously adapted for murine hearts \[[@CR3]\] was used. In brief, mice were killed by cervical dislocation \[Schedule 1: UK Animals (Scientific Procedures) Act 1986\]. Hearts were then quickly excised and placed in ice-cold bicarbonate-buffered Krebs--Henseleit solution. A short section of aorta was cannulated under the surface of the solution and attached to a custom-made 21-gauge cannula filled with the same solution using an aneurysm clip (Harvard Apparatus, Edenbridge, Kent, UK). Fresh Krebs--Henseleit solution was then passed through 200- and 5-μm filters (Millipore, Watford, UK) and warmed (37°C) using a water jacket and circulator (Techne model C-85A, Cambridge, UK) before being used for constant-flow retrograde perfusion at 2--2.5 ml/min using a peristaltic pump (Watson-Marlow Bredel model 505S, Falmouth, Cornwall, UK). Hearts were only regarded as suitable for experimentation if they regained a healthy pink colour and began to contract spontaneously on rewarming.

Electrophysiological measurements {#Sec6}
---------------------------------

An epicardial MAP electrode (Hugo Sachs, Harvard Apparatus) was placed against the basal left ventricular epicardium. A small access window was created in the interventricular septum to allow access to the left ventricular endocardium \[[@CR5]\]. A custom-made endocardial MAP electrode comprising two twisted strands of high-purity Teflon-coated silver wire of 0.25-mm diameter (Advent Research Materials, UK) was constructed. The Telflon coat was removed from the distal 1 mm of the electrode, which was then galvanically chlorided to eliminate DC offset, inserted and placed against the septal endocardial surface. MAPs were amplified, band-pass-filtered (0.5 Hz to 1 kHz: Gould 2400S, Gould-Nicolet Technologies, Ilford, Essex, UK) and digitised at a sampling frequency of 5 kHz (micro1401, Cambridge Electronic Design, Cambridge, UK). Analysis of MAPs in both the time and frequency domains was performed using Spike II (Cambridge Electronic Design).

Experimental protocol {#Sec7}
---------------------

A bipolar platinum stimulating electrode (1 mm inter-pole spacing) was placed on the basal surface of the right ventricular epicardium. Square-wave stimuli (Grass S48 stimulator, Grass-Telefactor, Slough, UK) of 2-ms duration and amplitudes of twice the excitation threshold were initially applied to hearts at a constant baseline cycle length of 125 ms until MAPs showed stable baselines, rapid upstroke phases that reached consistent amplitudes and smooth repolarisation phases \[[@CR19]\] and for at least 10 min. Hearts were then exposed to test solutions for 20 min while stimulation was continued before subsequent recordings were made.

In initial experiments, MAPs were recorded during regular stimulation at baseline cycle lengths of 130, 100 and 70 ms. Hearts were then subjected to an adapted *dynamic pacing protocol* \[[@CR9]\]. This comprised cycles each consisting of 100 stimuli delivered over a range of BCLs. Steady states were consistently reached during the first 50 responses in each cycle, and thus, mean epicardial and endocardial APD~90~ values and DIs were calculated from the final 50 action potentials of each cycle. With each successive cycle, BCL was decremented by 5-ms steps from an initial value of 175 ms. Cycles were continued until a reproducible sequence of consistently shaped waveforms was no longer obtained. These data were then used to construct restitution curves.

All data are presented as means ± standard errors of the means and include the number of hearts studied. Comparisons between data sets used analysis of variance (significance threshold set at *P* ≤ 0.05). Curve fitting of particular function to data sets used a Levenberg--Marquardt algorithm (OriginPro 7.5, OriginLab, MA, USA).

Results {#Sec8}
=======

The experiments explored the consequences of increases in heart rate for arrhythmogenicity in hypokalaemic murine hearts, thereby extending a previous report that considered the effect of bradycardia \[[@CR41]\]. They thus studied identical experimental groups, first exposing hearts to normokalaemic (5.2 mM K^+^) and hypokalaemic (3.0 mM K^+^) test solutions before and after addition of lidocaine (10 μM) for 20 min during regular stimulation at a BCL of 125 ms. Experiments then proceeded to study electrical activity through a range of steady state BCLs to assess propensity to spontaneous arrhythmia. Electrical traces from arrhythmic hearts were then quantitatively analysed in the frequency domain to empirically characterise their kinetics. Finally, hearts were subjected to a dynamic pacing protocol which explored the effect of varying BCLs \[[@CR21]\] and permitted the analysis of alternans and its relationship to arrhythmogenicity.

Alternans and arrhythmic activity occur in hypokalaemic hearts paced at a reduced baseline cycle length {#Sec9}
-------------------------------------------------------------------------------------------------------

The first series of experiments recorded MAPs \[[@CR23]\] from the epicardia of hearts paced at BCLs of 130, 100 or 70 ms over 30-min recording periods (five hearts in each case; Fig. [1](#Fig1){ref-type="fig"}). This demonstrated a tendency to both alternans, as reflected in alternating short-long-short sequences in action potential duration, and arrhythmogenesis at the shortest BCLs, corresponding to the highest heart rates, specifically in the hypokalaemic hearts and not in the other groups. Thus, MAPs obtained from normokalaemic hearts whether paced at BCLs of 130, 100 or 70 ms demonstrated consistent waveforms and stable rhythms during 30-min recording periods (five hearts in each case; Fig. [1](#Fig1){ref-type="fig"}a). In contrast, while recordings from hypokalaemic hearts paced at BCLs of 130 and 100 ms demonstrated stable rhythms (five out of five hearts), alternans leading to periods of arrhythmic activity occurred during pacing at a BCL of 70 ms in all five cases (*P* \< 0.01 as compared to normokalaemic hearts; Fig. [1](#Fig1){ref-type="fig"}b). However, neither alternans nor arrhythmic activity occurred in either normokalaemic or hypokalaemic hearts treated with lidocaine during pacing at any BCL (five hearts in each case; *P* \< 0.01 as compared to hypokalaemic hearts not treated with lidocaine; Fig. [1](#Fig1){ref-type="fig"}c and d, respectively), confirming the anti-arrhythmic effect of lidocaine described in earlier studies \[[@CR6], [@CR41], [@CR42], [@CR48]\]. Fig. 1Effect of baseline cycle length on presence of alternans and initiation of arrhythmic activity. Epicardial monophasic action potential recordings obtained from hearts exposed to normokalaemic (5.2 mM K^+^, **a**) and hypokalaemic (3.0 mM K^+^, **b**) test solutions, and normokalaemic (**c**) and hypokalaemic (**d**) test solutions containing lidocaine (10 μM) during regular stimulation at baseline cycle lengths of 130 ms (*A*), 100 ms (*B*) and 70 ms (*C*). *Vertical lines* indicate the timing of stimuli

Electrophysiological waveforms after the initiation of arrhythmic activity {#Sec10}
--------------------------------------------------------------------------

When arrhythmic activity was observed in those hypokalaemic hearts paced at a BCL of 70 ms, this showed progressive degeneration from a regular monomorphic to a disorganised polymorphic pattern (four hearts), in common with earlier reports from the larger, porcine and human, hearts \[[@CR16], [@CR58], [@CR63]\].

This trend was quantitatively apparent in a spectral analysis performed using a fast Fourier transform method \[[@CR4]\] on ∼10-s sequences of MAP waveforms recorded from the epicardia and endocardia of hypokalaemic hearts to which a Hanning window had first been applied. These waveforms had been sampled at a rate of 5 kHz with low- and high-frequency filter cutoffs of 0.5 Hz and 1 kHz, respectively. Each transform was performed on 16,384 (=2^16^) points to give a spectral resolution of 0.30 Hz up to a maximum, Nyquist, frequency of 2.5 kHz. Relative root mean square powers were then extracted from the real and imaginary parts of the transforms.

Figure [2](#Fig2){ref-type="fig"} thus compares typical waveforms in both the time (a) and frequency (b) domains. Waveforms recorded during the first ∼5 min after the initiation of arrhythmic activity were monomorphic in appearance (*A* in Fig. [2](#Fig2){ref-type="fig"}a). This was confirmed by spectral analysis which similarly demonstrated a single identical dominant frequency peak of 18.9 ± 1.8 Hz in both epicardial and endocardial recordings with harmonics whose frequencies were integral multiples of a dominant fundamental frequency and any given heart showed at least two such peaks (∼38.4, ∼57.6, ∼76.8 Hz, *A* in Fig. [2](#Fig2){ref-type="fig"}b). Fig. 2Progression from monomorphic to polymorphic arrhythmic activity. Epicardial and endocardial monophasic action potential recordings obtained from hearts exposed to hypokalaemic (3.0 mM K^+^) test solution 5 min (*A*) and 10 min (*B*) after initiation of arrhythmic activity in the time (**a**) and frequency (**b**) domains

In contrast, waveforms recorded ≥10 min after the initiation of arrhythmic activity were consistently polymorphic in appearance (*B* in Fig. [2](#Fig2){ref-type="fig"}a), with spectral analysis (*B* in Fig. [2](#Fig2){ref-type="fig"}b) further demonstrating dissimilar epicardial and endocardial frequency spectra. The dominant frequency peak was then at 27.6 ± 5.6 Hz in the epicardium, while that in the endocardium was 26.5 ± 5.8 Hz. Furthermore, the higher order peaks, whether recorded from the epicardium or the endocardium, occurred at irregular frequency intervals that were not multiples of the dominant frequency.

Alternans occurs in the epicardia and endocardia of hypokalaemic hearts paced at a baseline cycle length of 70 ms {#Sec11}
-----------------------------------------------------------------------------------------------------------------

As illustrated in *C* in Fig. [1](#Fig1){ref-type="fig"}b, hypokalaemic hearts paced at a BCL of 70 ms demonstrated alternans. Figure [3](#Fig3){ref-type="fig"} goes on to show mean APD~90~ values of the alternating, odd-numbered (filled bars) and even-numbered (open bars) action potentials, and the difference between these values, giving the magnitude of any alternans (hashing), recorded from the epicardia (a) and endocardia (b) under normokalaemic (A) and hypokalaemic (B) conditions and under such conditions during treatment with lidocaine (C and D, respectively). Fig. 3Alternans during stimulation at a baseline cycle length of 70 ms. Durations of successive odd (*filled bars*) and even (*open bars*) numbered action potentials (at 90% repolarisation, APD~90~) and the difference between these values, giving the magnitude of alternans (hashing) in the epicardia (**a**) and endocardia (**b**) of hearts exposed to normokalaemic (5.2 mM K^+^, *A*) and hypokalaemic (3.0 mM K^+^, *B*) test solutions and normokalaemic (*C*) and hypokalaemic (*D*) test solutions containing lidocaine (10 μM) during regular stimulation at a baseline cycle length of 70 ms

In normokalaemic hearts (five hearts), alternans was not observed, the difference between the mean APD~90~ values of odd-number and even-numbered action potentials not reaching significance (*P* \> 0.05) in either the epicardium (4.7 ± 2.7 ms) or the endocardium (5.6 ± 1.7 ms). In contrast, alternans did occur in hypokalaemic hearts (five hearts), the difference between the mean APD~90~ values of odd-number and even-numbered action potentials being statistically significant (*P* \< 0.01) in both epicardium (14.9 ± 3.8 ms) and endocardium (15.6 ± 1.8 ms). Treatment with lidocaine had no significant (*P* \> 0.05) effect on normokalaemic hearts (five hearts): The difference between the mean APD~90~ values of odd-number and even-numbered action potentials remained statistically insignificant (*P* \> 0.05) in both epicardium (2.7 ± 3.4 ms) and endocardium (2.5 ± 4.6 ms). In contrast, treatment with lidocaine eliminated alternans in hypokalaemic hearts (five hearts). Hence, the difference between the mean APD~90~ values of odd-number and even-numbered action potentials did not reach significance (*P* \> 0.05) in either epicardium (4.1 ± 4.6 ms) or endocardium (2.4 ± 3.2 ms).

The dynamic pacing protocol initiates alternans in hypokalaemic hearts at short baseline cycle lengths {#Sec12}
------------------------------------------------------------------------------------------------------

The above findings concerning the presence or absence of alternans at the shortest BCL studied above prompted a detailed exploration of the effect of BCL upon the alternans phenomenon. To assess this relationship, hearts were subjected to a dynamic pacing protocol \[[@CR21]\] consisting of cycles each lasting 100 stimuli at through a range of BCLs. In these procedures, steady states were consistently reached within the first 50 responses. Accordingly, mean values of epicardial and endocardial APD~90~ and DI were obtained from the final 50 action potentials. BCL was decremented in 5-ms steps with each cycle from an initial value of 175 ms until a reproducible sequence of consistently shaped action potential waveforms could no longer be obtained.

Figure [4](#Fig4){ref-type="fig"}a--d shows typical recordings obtained from the epicardia of individual hearts under the four sets of experimental conditions during the dynamic pacing protocol at BCLs of 170, 130, 90, 85, 80, 75 and 70 ms when such steady states had been achieved. Figure [5](#Fig5){ref-type="fig"}a--d shows the corresponding relationships between the durations of successive odd- and even-numbered action potentials obtained from these same hearts during the dynamic pacing protocol over the full range of BCLs studied. Thus, alternans was not observed under normokalaemic conditions even at the shortest BCL studied (Fig. [4](#Fig4){ref-type="fig"}a), resulting in points falling on the line *y* = *x* (Fig. [5](#Fig5){ref-type="fig"}a). Conversely, alternans occurred under hypokalaemic conditions at short BCLs (Fig. [4](#Fig4){ref-type="fig"}b), resulting in such points falling below the line of equality (Fig. [5](#Fig5){ref-type="fig"}b). In contrast, alternans did not occur in either normokalaemic or hypokalaemic hearts during exposure to lidocaine (Fig. [4](#Fig4){ref-type="fig"}c and d), again resulting in points falling on the line of equality (Fig. [5](#Fig5){ref-type="fig"}c and d). Fig. 4Effect of baseline cycle length on action potential waveforms. Epicardial monophasic action potential recordings obtained from hearts exposed to normokalaemic (5.2 mM K^+^, **a**) and hypokalaemic (3.0 mM K^+^, **b**) test solutions and normokalaemic (**c**) and hypokalaemic (**d**) test solutions containing lidocaine (10 μM) during stimulation at baseline cycle lengths of 170, 130, 90, 85, 80, 75 and 70 ms. *Vertical lines* indicate the timing of stimuliFig. 5Relationships between durations of successive action potentials over a range of baseline cycle lengths. Relationships between the durations of successive odd- and even-numbered epicardial monophasic action potentials (at 90% repolarisation, APD~90~) in the same hearts exposed to normokalaemic (5.2 mM K^+^, **a**) and hypokalaemic (3.0 mM K^+^, **b**) test solutions and normokalaemic (**c**) and hypokalaemic (**d**) test solutions containing lidocaine (10 μM). These were obtained at baseline cycle lengths decremented in 5-ms steps from 175 ms until stimulation no longer resulted in a reproducible sequence of waveforms. *Filled* and *open circles* indicate data obtained at baseline cycle lengths at which arrhythmogenesis was and was not observed, respectively. *Arrow* indicates departure of points from the line *y* = *x* (*broken line*)

Alterations in the slopes of restitution curves correlate with pro- and anti-arrhythmic effects {#Sec13}
-----------------------------------------------------------------------------------------------

The findings described above prompted the construction and analysis of restitution curves relating APD~90~ and the preceding DI given by the difference between the BCL and the preceding APD~90~ \[[@CR21], [@CR29], [@CR32], [@CR55]\]. Alternans and arrhythmia have previously been associated with increases in the slopes of such restitution curves reflecting disproportionate decreases in mean APD~90~ with DI. Such curves (data points, left ordinate) were plotted using the APD~90~ (left ordinate) and DI data obtained from the epicardia (circles, Fig. [6](#Fig6){ref-type="fig"}*A*) and endocardia (squares, Fig. [6](#Fig6){ref-type="fig"}*B*) of hearts under these conditions (a--d, respectively). Fig. 6Restitution curves obtained from epicardia and endocardia. Restitution curves plotting action potential duration (at 90% repolarization, APD~90~) against preceding diastolic interval (*DI*) obtained from the epicardia (*circles*, *A*) and endocardia (*squares*, *B*) of hearts exposed to normokalaemic (5.2 mM K^+^, **a**) and hypokalaemic (3.0 mM K^+^, **b**) test solutions and normokalaemic (**c**) and hypokalaemic (**d**) test solutions containing lidocaine (10 μM). Curves are fitted with mono-exponential growth functions obtained by least-squares fitting to the experimental values of APD~90~ and DI (*solid lines*, left ordinates). Gradients were obtained by differentiation of the fitted functions (*broken lines*, right axes). *Shaded boxes* indicate ranges of DI values at which such gradients exceed unity

Under all conditions, both epicardial and endocardial APD~90~ decreased as DI decreased. However, the slope of this relationship was greater under hypokalaemic (*A* and *B* in Figs. [6](#Fig6){ref-type="fig"}b) than under normokalaemic conditions (*A* and *B* in Figs. [6](#Fig6){ref-type="fig"}a). This paralleled both the alternans and arrhythmic activity that were observed under the hypokalaemic conditions. Such increases in the slopes of restitution curves were observed even when the DI was so short such that stimuli were delivered before 90% repolarisation was achieved. This would tend to result in the underestimation of APD~90~, and hence, the *underestimation* of the slopes of restitution curves.

Exposure to lidocaine had little effect on the slopes of the corresponding curves obtained under normokalaemic (*A* and *B* in Figs. [6](#Fig6){ref-type="fig"}c), but markedly decreased the slopes of curves obtained under hypokalaemic conditions (*A* and *B* in Figs. [6](#Fig6){ref-type="fig"}d), in precise agreement with its corresponding effects in suppressing alternans and arrhythmia.

Restitution curves yield parameters predictive of arrhythmogenicity {#Sec14}
-------------------------------------------------------------------

The restitution curves obtained above proved amenable to quantitative analyses that has been described on previous occasions. For example, the simplest, mono-exponential growth function that has been used to describe data of this kind \[[@CR13]\] takes the form: $$\documentclass[12pt]{minimal}
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Figure [6](#Fig6){ref-type="fig"} plots the original APD~90~ and DI values and superimposes optimisations of Eq. [1](#Equ1){ref-type=""} to these data (solid lines, left-hand ordinates). Such optimisations gave reduced *χ*^2^ values indicative of better fits to data points obtained under normokalaemic than hypokalaemic conditions. It also shows the corresponding gradients derived from constants obtained from the optimisations (Eq. [2](#Equ2){ref-type=""}: broken lines, right-hand axes). Shaded regions where present indicate the range of DIs below a critical DI (DI \< critical DI) at which these gradients exceed unity, obtained from Eq. [2](#Equ2){ref-type=""}: $$\documentclass[12pt]{minimal}
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Such a phenomenon is associated with an alternans initiated by incomplete recovery of one action potential and the consequent shortening of its subsequent DI. This would result in a disproportionate shortening of the subsequent action potential which would consequently permit its full recovery and a lengthening of the DI that follows, thereby reinitiating the cycle and resulting in a progressive decrease in mean APD~90~ relative to mean DI with decreasing BCL \[[@CR29]\].

The resulting alternans would assume an amplitude determined by the gradient of the restitution curve at the given BCL, whether the latter is determined by altered external pacing rates or local ventricular arrhythmic activity. A BCL that gives a gradient of \>1 will then initiate a shortening not only of mean APD~90~ but also of mean APD~90~ relative to mean DI. The resulting shortening of action potential wavelength would then predispose to reentry and arrhythmogenesis.

These parameters successfully predict the pro-arrhythmic effect of hypokalaemia {#Sec15}
-------------------------------------------------------------------------------

Figure [7](#Fig7){ref-type="fig"} goes on to show these maximum gradients (a) and values of the critical DI (b) derived from the computed *A* and *τ* values in epicardia (filled bars) and endocardia (open bars). Under normokalaemic conditions (Fig. [7](#Fig7){ref-type="fig"}A) *A* and *τ* took values of 56.3 ± 2.4 ms and 58.4 ± 9.8 ms in the epicardium and 73.8 ± 1.7 ms and 65.2 ± 8.4 ms in the endocardium, with reduced *χ*^2^ values from least-squares regression of $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ \chi ^{2}_{R}  $$\end{document}$ = 1.4 and 1.2, respectively. This gave maximal gradients of 0.55 ± 0.14 in the epicardium and 0.67 ± 0.13 in the endocardium and critical DI values of −2.14 ± 0.52 ms and 8.14 ± 1.49 ms, respectively. None of the experimental DI values realised the critical DI in either the epicardium or the endocardium, paralleling the absence of arrhythmic activity (Fig. [2](#Fig2){ref-type="fig"}a). Fig. 7Maximum gradients and critical diastolic intervals obtained from restitution curves. Maximum gradients (**a**) and critical diastolic intervals at which gradients equalled unity (**b**) obtained from epicardial (*filled bars*) and endocardial (*open bars*) restitution curves shown in Fig. [6](#Fig6){ref-type="fig"} under normokalaemic (5.2 mM K^+^, *A*) and hypokalaemic (3.0 mM K^+^, *B*) conditions and under normokalaemic (*C*) and hypokalaemic (*D*) conditions during exposure to lidocaine (10 μM). *Asterisks* indicate values that are significantly (*P* \< 0.05) larger than those recorded in normokalaemic hearts

Hypokalaemia (Fig. [7](#Fig7){ref-type="fig"}B) significantly (*P* \< 0.05) increased the slopes of both epicardial and endocardial curves, concurring with the arrhythmogenic findings. Thus, *A* and *τ* took values of 166.7 ± 5.63 ms and 29.3 ± 8.29 ms in the epicardium and 133.3 ± 8.0 ms and 29.8 ± 2.1 ms in the endocardium, with $\documentclass[12pt]{minimal}
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\begin{document}$$ \chi ^{2}_{R}  $$\end{document}$ values of 8.2 and 2.5, respectively. This gave significantly (*P* \< 0.05) increased maximum gradients of 2.35 ± 0.67 in the epicardium and 1.87 ± 0.28 in the endocardium and significantly (*P* \< 0.05) increased the critical DI values of 50.93 ± 14.45 ms and 44.64 ± 5 ms, respectively. The critical DI was realised by the observed data points in both epicardium and endocardium. Furthermore, the DIs at which this occurred were in full agreement with the corresponding DIs at which alternans was observed. Thus, in the epicardium, alternans occurred during pacing at BCLs of ≤95 ms, corresponding to DIs of 46.7 ± 3.6 ms, while in the endocardium, alternans occurred during pacing at BCLs of ≤75 ms, corresponding to DIs of 44.0 ± 5.7 ms.

These parameters also predict the anti-arrhythmic effect of lidocaine {#Sec16}
---------------------------------------------------------------------

Lidocaine had no significant (*P* \> 0.05) effect on these values when applied to normokalaemic hearts (Fig. [7](#Fig7){ref-type="fig"}C). Thus, *A* and *τ* took values of 81.1 ± 3.05 ms and 56.92 ± 10.29 ms in the epicardium and 104.47 ± 13.69 ms and 97.17 ± 36.22 ms in the endocardium, with $\documentclass[12pt]{minimal}
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\begin{document}$$ \chi ^{2}_{R}  $$\end{document}$ values of 5.37 and 10.47, respectively. This gave maximum gradients of 0.78 ± 0.27 in the epicardium and 0.83 ± 0.45 in the endocardium and the critical DI values of 6.06 ± 2.10 ms and 7.04 ± 3.82 ms, respectively, which were not realised even at the shortest BCLs studied.

In contrast, treatment of hypokalaemic hearts with lidocaine (Fig. [7](#Fig7){ref-type="fig"}D) significantly (*P* \< 0.05) reduced the slopes of both epicardial and endocardial restitution curves, in parallel with its anti-arrhythmic effect. Thus *A* and *τ* took values of 109.90 ± 11.95 ms and 37.36 ± 5.97 ms in the epicardium and 231.72 ± 44.70 ms and 27.60 ± 4.44 ms in the endocardium, with $\documentclass[12pt]{minimal}
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\begin{document}$$ \chi ^{2}_{R}  $$\end{document}$ values of 6.83 and 15.68, respectively. This gave significantly decreased (*P* \< 0.05) maximal gradients of 1.05 ± 0.30 in the epicardium and 0.89 ± 0.36 in the endocardium and significantly decreased (*P* \< 0.05) critical DI values of 30.38 ± 8.88 ms and 31.65 ± 4.78 ms, respectively. The critical DI was realised only at the shortest BCLs studied and then only in the epicardium, in parallel with the substantial reduction in arrhythmogenicity produced by this drug.

Slopes of restitution curves thus precisely correlate with the presence or absence of alternans and arrhythmogenesis under all the conditions explored in the hypokalaemic Langendorff-perfused murine heart.

Discussion {#Sec17}
==========

Electrical alternans, beat-to-beat alternation in action potential duration in turn reflected in alternation in electrocardiographic QT interval (QT or T-wave alternans), is most commonly seen at high heart rates and has been associated with arrhythmogenesis in both clinical \[[@CR2], [@CR25], [@CR28], [@CR38]\] and experimental \[[@CR7], [@CR33], [@CR52]\] studies. This association is especially marked in situations of preexisting action potential, and therefore electrocardiographic QT, prolongation \[[@CR39], [@CR46], [@CR47], [@CR49], [@CR64]\] as might occur in the congenital long QT syndromes.

Alternans phenomena have classically been analysed by the construction of restitution curves relating action potential duration to the preceding diastolic interval as heart rate is varied \[[@CR29]\]. Restitution curves of slopes greater than unity have been associated with alternations in action potential durations of progressively increasing magnitude \[[@CR14], [@CR21], [@CR24], [@CR29], [@CR32]\]. In contrast alternans has more recently been associated with disruption of normal cellular Ca^2+^ homeostasis leading to alternating short-long-short pulses of release from sarcoplasmic reticular stores \[[@CR35], [@CR44], [@CR54]\]. Irrespective of the underlying mechanism, any spatial discordance in either phase or magnitude of alternans between myocardial regions would lead to spatial repolarisation gradients that might cause reentry and arrhythmogenesis \[[@CR53], [@CR56]\]. Furthermore, any resulting decrease in action potential wavelength, given by the product of action potential duration and conduction velocity, to less than a critical value, might break up the propagating wave of excitation and lead to reentry and arrhythmogenesis \[[@CR55]\].

Relationships between restitution curve slopes, alternans and arrhythmogenicity at high heart rates have been established in canine preparations made to model congenital long QT syndrome type 2 (LQT2) by application of the *I*~Kr~ blocking agent E-4031 \[[@CR27], [@CR61]\]. Correspondingly, there is a known association between sudden arousal, presumably resulting in increased heart rate, and arrhythmogenesis in human LQT2 \[[@CR59]\]. This association has also been established in clinical hypokalaemia \[[@CR11]\]. This common and pathophysiologically important condition similarly results in decreased repolarising K^+^ currents, together with action potential, and therefore electrocardiographic QT, prolongation \[[@CR17], [@CR62]\].

The experiments reported recorded MAP technique \[[@CR19], [@CR23]\] from an established intact hypokalaemic murine model \[[@CR18], [@CR40]--[@CR42]\] and explored for alternans and arrhythmogenicity and the relationship between these before proceeding to study the effect of lidocaine upon these phenomena. Such studies of *temporal* heterogeneities in recovery were made at short BCLs in contrast to recent work \[[@CR40], [@CR41]\] which examined *spatial* heterogeneities at long BCLs. The murine system utilised facilitates the introduction of genetic modifications \[[@CR26]\] and may therefore permit future comparisons with models replicating congenital arrhythmic syndromes. Indeed, alternans, in association with arrhythmogenicity, has previously been demonstrated in a murine model of LQT5 \[[@CR50]\].

While the murine heart is well established as a model for human disease, it must be noted that important interspecies differences exist. Thus, differences between humans and mice in the kinetics of the ion channels carrying the key repolarising currents (the delayed rectifier and slowly-inactivating delayed rectifier currents, *I*~Kr~ and *I*~Ks~, in humans and the transient outward current, *I*~to~ in mice) result in shorter ventricular AP and the absence of a plateau phase in mice \[[@CR2]\]. However, in both species, these key repolarising currents are K^+^-sensitive \[[@CR6], [@CR11], [@CR16]\], making the murine heart well suited to modelling clinical hypokalaemia. Furthermore, in both species, depolarisation is rapid and attributable to the same fast Na^+^ current (*I*~Na,f~) \[[@CR4]\], making our model well suited to the study of Na^+^-channel-blocking agents such as lidocaine. While both species share similar differences in AP duration between epicardium and endocardium \[[@CR7]\], M cells appear to be absent in the murine heart \[[@CR1]\]. Nonetheless, relationships between APD and refractory period are similar between the two species \[[@CR3], [@CR8]\], and transmural conduction velocities are almost identical \[[@CR5], [@CR10]\]. With these caveats in mind, similarities between human and murine hearts make our murine model well suited for the study of the basic mechanisms of arrhythmogenicity.

First, we confirm that alternans is absent in control normokalaemic hearts and that this is associated with the maintenance of stable rhythms even at short BCLs. Secondly, we report alternans in association with arrhythmogenesis at short BCLs for the first time in hypokalaemic murine hearts, in full agreement with previous clinical and experimental studies in other species \[[@CR2], [@CR7], [@CR33], [@CR38], [@CR52]\].

Thirdly, we associate such alternans with increases in the slopes of restitution curves above unity \[[@CR29], [@CR55]\]. Fourthly, we demonstrate for the first time in any experimental model that exposure to the class I agent lidocaine reduces the slopes of restitution curves and suppresses alternans in association with its anti-arrhythmic effect. Taken together, these observations implicate a restitution mechanism in driving alternans in these hypokalaemic preparations. Furthermore, this extends previous reports that the anti-arrhythmic effects of both class III and IV agents are associated with decreases in the slopes of restitution curves \[[@CR8], [@CR31], [@CR37]\]. This contrasts with a previous report that found lidocaine to have no effect on restitution curves obtained using an extrasystolic stimulation procedure or alternans phenomena in a normokalaemic excised canine papillary muscle preparation \[[@CR43]\].

Fifthly, we show that such alternans and steeply sloping restitution curves are associated with the temporal evolution of the normal regular pattern of cardiac excitation into arrhythmic activity. The latter, in turn, was processed by a spectral Fourier transform analysis of MAP waveforms performed for the first time in any cardiac system. Arrhythmic MAP waveforms were initially monomorphic, and their corresponding spectra contained a single dominant frequency and integral multiple harmonics identical in epicardial and endocardial recordings. Such monomorphic arrhythmic waveforms subsequently degenerated into polymorphic waveforms whose spectra showed dissimilar epicardial and endocardial dominant frequencies and larger higher order peaks that were not integral multiples of the dominant frequency in full agreement with previous results from the porcine heart \[[@CR63]\]. Spectra with similar features have previously been obtained from volume-conducted electrograms and pseudoelectrograms (as opposed to MAPs) from murine hearts during both monomorphic and polymorphic arrhythmic activity \[[@CR51]\].

Taken together, these results recapitulate in a murine system arrhythmogenic patterns classically described in clinical situations \[[@CR16], [@CR58]\] and implicate a dynamic component to arrhythmic substrate under conditions of hypokalaemia for which restitution may furnish a possible underlying mechanism. Furthermore, they disprove previous suggestions that small hearts are unable to sustain such arrhythmias \[[@CR9], [@CR60]\], and thus further validate the murine heart as a model for the study of clinical arrhythmia. The present findings might therefore form a basis for further explorations of the relationships between heart rate, restitution slopes, alternans and arrhythmogenicity in other states of QT prolongation, whether attributable to congenital or acquired factors.
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